Composition and method for treating diabetes
CA 2463769 A1 · Owner: Medical College Of Hampton Roads D/B/A Eastern Virginia Medical School · Inventors: Taylor-Fishwick, David; Mohrland, Scott; Vinik, Aaron I.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention comprises dosing regimens and formulations of islet cell neogenesis associated protein (INGAP) and INGAP Peptide. The formulation disclosed herein is shown have acceptable stability as a pharmaceutical composition. Further, the formulation is able to regenerate functional islets
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 15, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 15, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 15, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.